Perceptive Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-101,000
Closed -$3.16M 106
2023
Q4
$3.16M Buy
+101,000
New +$3.16M 0.07% 82
2022
Q2
Sell
-284,853
Closed -$6.9M 110
2022
Q1
$6.9M Sell
284,853
-1,299,199
-82% -$31.5M 0.14% 94
2021
Q4
$37M Buy
+1,584,052
New +$37M 0.57% 46
2021
Q2
Sell
-1,410,305
Closed -$36.4M 149
2021
Q1
$36.4M Buy
+1,410,305
New +$36.4M 0.46% 52
2020
Q1
Sell
-11,256
Closed -$482K 111
2019
Q4
$482K Buy
+11,256
New +$482K 0.01% 104
2019
Q2
Sell
-14,897
Closed -$400K 103
2019
Q1
$400K Buy
+14,897
New +$400K 0.01% 92
2018
Q2
Sell
-275,000
Closed -$6.18M 126
2018
Q1
$6.18M Buy
+275,000
New +$6.18M 0.17% 74
2017
Q1
Hold
0
159
2016
Q4
Sell
-65,240
Closed -$2.08M 174
2016
Q3
$2.08M Sell
65,240
-100,000
-61% -$3.18M 0.13% 84
2016
Q2
$5.36M Sell
165,240
-90,000
-35% -$2.92M 0.37% 51
2016
Q1
$7.14M Buy
255,240
+10,000
+4% +$280K 0.63% 42
2015
Q4
$8.74M Sell
245,240
-50,000
-17% -$1.78M 0.65% 35
2015
Q3
$9.76M Sell
295,240
-115,000
-28% -$3.8M 0.78% 24
2015
Q2
$17.2M Sell
410,240
-190,000
-32% -$7.96M 1.03% 22
2015
Q1
$19.6M Sell
600,240
-493,041
-45% -$16.1M 1.52% 18
2014
Q4
$34.7M Sell
1,093,281
-4,633
-0.4% -$147K 2.91% 8
2014
Q3
$27.2M Buy
1,097,914
+444,914
+68% +$11M 2.75% 9
2014
Q2
$14.8M Sell
653,000
-13,000
-2% -$294K 1.45% 23
2014
Q1
$16.2M Buy
+666,000
New +$16.2M 1.7% 17
2013
Q4
Sell
-610,615
Closed -$16.8M 101
2013
Q3
$16.8M Sell
610,615
-116,014
-16% -$3.19M 1.36% 16
2013
Q2
$13.2M Buy
+726,629
New +$13.2M 1.33% 15